New York State Teachers Retirement System (NYSTRS)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.8M | Sell |
93,762
-14,719
| -14% | -$1.85M | 0.02% | 474 |
|
2025
Q1 | $12M | Sell |
108,481
-2,055
| -2% | -$227K | 0.03% | 452 |
|
2024
Q4 | $15.1M | Sell |
110,536
-4,514
| -4% | -$616K | 0.03% | 410 |
|
2024
Q3 | $13.3M | Buy |
115,050
+2,017
| +2% | +$232K | 0.03% | 468 |
|
2024
Q2 | $15.6M | Buy |
113,033
+9,723
| +9% | +$1.34M | 0.03% | 404 |
|
2024
Q1 | $14.2M | Buy |
103,310
+1,541
| +2% | +$213K | 0.03% | 447 |
|
2023
Q4 | $13.4M | Buy |
101,769
+4,780
| +5% | +$630K | 0.03% | 443 |
|
2023
Q3 | $10.9M | Buy |
96,989
+740
| +0.8% | +$83.2K | 0.03% | 474 |
|
2023
Q2 | $9.08M | Hold |
96,249
| – | – | 0.02% | 560 |
|
2023
Q1 | $9.74M | Sell |
96,249
-1,055
| -1% | -$107K | 0.02% | 530 |
|
2022
Q4 | $11.6M | Buy |
97,304
+18,041
| +23% | +$2.15M | 0.03% | 468 |
|
2022
Q3 | $8.42M | Buy |
79,263
+4,289
| +6% | +$456K | 0.02% | 547 |
|
2022
Q2 | $7.31M | Buy |
74,974
+16,200
| +28% | +$1.58M | 0.02% | 624 |
|
2022
Q1 | $5.51M | Sell |
58,774
-1,275
| -2% | -$120K | 0.01% | 782 |
|
2021
Q4 | $5.11M | Buy |
60,049
+20,198
| +51% | +$1.72M | 0.01% | 827 |
|
2021
Q3 | $3.82M | Sell |
39,851
-83
| -0.2% | -$7.96K | 0.01% | 932 |
|
2021
Q2 | $3.89M | Buy |
39,934
+19,734
| +98% | +$1.92M | 0.01% | 924 |
|
2021
Q1 | $1.96M | Buy |
+20,200
| New | +$1.96M | ﹤0.01% | 1152 |
|
2020
Q4 | – | Sell |
-1,900
| Closed | -$183K | – | 1643 |
|
2020
Q3 | $183K | Buy |
1,900
+1,400
| +280% | +$135K | ﹤0.01% | 1495 |
|
2020
Q2 | $61K | Buy |
+500
| New | +$61K | ﹤0.01% | 1545 |
|